{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:56:23Z","timestamp":1768434983039,"version":"3.49.0"},"reference-count":30,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"unspecified","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020424","name":"Weill Cornell Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020424","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spiegel Fund"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2023,9,14]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Tissue damage in lupus nephritis (LN) is mediated by activation of the classical complement pathway. Complement-mediated upregulation of endothelial cell adhesion molecules is seen in dermal blood vessels of non-lesional skin of patients with active lupus. In diseases with systemic complement activation, extensive microvascular C5b-9 deposition is seen in non-lesional skin. In this study, we assess the presence of systemic complement pathway activation as determined by non-lesional skin microvascular C5b-9 deposition in patients with LN.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Eight patients with active LN and eight patients without active LN underwent non-lesional skin biopsies. Using a diaminobenzidine technique, specimens were evaluated for microvascular C5b-9 consistent with systemic complement pathway activation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Five of eight patients with active LN and one of eight patients without active LN demonstrated positive C5b-9 staining in non-lesional skin (p=0.04). Positive non-lesional C5b-9 staining has greater specificity, 87.5%, for active LN than pyuria, low complements, elevated double-stranded DNA (dsDNA) and proteinuria. Urine protein creatinine ratio was significantly higher in patients with positive non-lesional C5b-9 deposition (5.18 vs 1.20; p=0.04). C5b-9 deposition was not associated with a higher NIH Activity Index, interstitial fibrosis, dsDNA or lower complements.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This is the first study to demonstrate evidence in non-lesional skin of microvascular C5b-9 indicative of systemic complement pathway activation in LN. C5b-9 deposition is statistically more common and demonstrated greater specificity than most historical biomarkers for active LN. The findings support a potential role for microvascular C5b-9 assessment in non-lesional skin as a biomarker for LN activity.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/lupus-2023-000996","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T03:26:40Z","timestamp":1698204400000},"page":"e000996","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Microvascular C5b-9 deposition in non-lesional skin in patients with SLE and its correlation with active lupus nephritis: a prospective observational study"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4587-9456","authenticated-orcid":false,"given":"Meghan","family":"Anderson","sequence":"first","affiliation":[{"name":"Department of Rheumatology, NYU Grossman School of Medicine, New York City, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Magro","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weill Cornell Medicine, New York City, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H Michael","family":"Belmont","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, NYU Grossman School of Medicine, New York City, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,10,24]]},"reference":[{"key":"2025091511543833000_10.2.e000996.1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013010026"},{"key":"2025091511543833000_10.2.e000996.2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000431278","article-title":"Complement in lupus nephritis: new perspectives","volume":"1","author":"Bao","year":"2015","journal-title":"Kidney Dis (Basel)"},{"key":"2025091511543833000_10.2.e000996.3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semarthrit.2018.01.004","article-title":"Membrane attack complex (Mac) deposition in lupus nephritis is associated with hypertension and poor clinical response to treatment","volume":"48","author":"Wang","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2025091511543833000_10.2.e000996.4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.kint.2018.09.027","article-title":"Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis","volume":"95","author":"Wilson","year":"2019","journal-title":"Kidney Int"},{"key":"2025091511543833000_10.2.e000996.5","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780401013"},{"key":"2025091511543833000_10.2.e000996.6","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370311"},{"key":"2025091511543833000_10.2.e000996.7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep034"},{"key":"2025091511543833000_10.2.e000996.8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/DAD.0000000000000234","article-title":"Role of the skin biopsy in the diagnosis of atypical hemolytic uremic syndrome","volume":"37","author":"Magro","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"2025091511543833000_10.2.e000996.9","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.ajpath.2022.05.006","article-title":"Premortem skin biopsy assessing microthrombi, interferon type I antiviral and regulatory proteins, and complement deposition correlates with coronavirus disease 2019 clinical stage","volume":"192","author":"Laurence","year":"2022","journal-title":"Am J Pathol"},{"key":"2025091511543833000_10.2.e000996.10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/bjd.19415","article-title":"The differing pathophysiologies that underlie COVID-19-associated Perniosis and thrombotic retiform purpura: a case series","volume":"184","author":"Magro","year":"2021","journal-title":"Br J Dermatol"},{"key":"2025091511543833000_10.2.e000996.11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.humpath.2020.10.002","article-title":"Docked severe acute respiratory syndrome coronavirus 2 proteins within the cutaneous and subcutaneous microvasculature and their role in the pathogenesis of severe coronavirus disease 2019","volume":"106","author":"Magro","year":"2020","journal-title":"Hum Pathol"},{"key":"2025091511543833000_10.2.e000996.12","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s41409-022-01723-5","article-title":"C5B-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"57","author":"Elhadad","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"2025091511543833000_10.2.e000996.13","doi-asserted-by":"crossref","DOI":"10.1002\/art.1780400928","article-title":"Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2025091511543833000_10.2.e000996.14","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1344"},{"key":"2025091511543833000_10.2.e000996.15","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000271","article-title":"Serum albumin at 1 year predicts long-term renal outcome in lupus nephritis","volume":"5","author":"Domingues","year":"2018","journal-title":"Lupus Sci Med"},{"key":"2025091511543833000_10.2.e000996.16","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2015-000123","article-title":"A proteinuria cut-off level of 0.7\u2005G\/day after 12\u2005months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN nephritis trial","volume":"2","author":"Tamirou","year":"2015","journal-title":"Lupus Sci Med"},{"key":"2025091511543833000_10.2.e000996.17","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05780616"},{"key":"2025091511543833000_10.2.e000996.18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41584-023-00925-5","article-title":"Treatment of lupus nephritis: consensus, evidence and perspectives","volume":"19","author":"Mok","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2025091511543833000_10.2.e000996.19","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1093\/ckj\/sfac150","article-title":"Kidney biopsy in lupus nephritis after achieving clinical renal remission: paving the way for renal outcome assessment","volume":"15","author":"Lled\u00f3-Ib\u00e1\u00f1ez","year":"2022","journal-title":"Clin Kidney J"},{"key":"2025091511543833000_10.2.e000996.20","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-004-0012-5"},{"key":"2025091511543833000_10.2.e000996.21","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000576","article-title":"Membrane attack complex (MAC) deposition in renal tubules is associated with interstitial fibrosis and tubular atrophy: a pilot study","volume":"9","author":"Wang","year":"2022","journal-title":"Lupus Sci Med"},{"key":"2025091511543833000_10.2.e000996.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.11.023"},{"key":"2025091511543833000_10.2.e000996.23","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018019596"},{"key":"2025091511543833000_10.2.e000996.24","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.409"},{"key":"2025091511543833000_10.2.e000996.25","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02870311"},{"key":"2025091511543833000_10.2.e000996.26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semarthrit.2018.11.005","article-title":"Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: case series and review of literature","volume":"49","author":"Kello","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"2025091511543833000_10.2.e000996.27","doi-asserted-by":"crossref","first-page":"1081942","DOI":"10.3389\/fimmu.2022.1081942","article-title":"Thrombotic microangiopathy mediates poor prognosis among lupus nephritis via complement lectin and alternative pathway activation","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"2025091511543833000_10.2.e000996.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900866"},{"key":"2025091511543833000_10.2.e000996.29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-06-856930"},{"key":"2025091511543833000_10.2.e000996.30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.16.8563"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2023-000996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T18:54:46Z","timestamp":1757962486000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2023-000996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,10,24]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/lupus-2023-000996"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2023-000996","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}